Bassam Damaj, President and CEO, 10% Owner at INNOVUS PHARMACEUTICALS, INC. (INNV), bought 250,406 shares at $0.48 ($120K) on 2013-02-02, disclosed to the SEC on 2013-02-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| APRI | BUY | 2012-08-21 | $4K | — | Filing → |